Penicillins and Streptomycins in Dosage Market Size Value in Belgium

The Penicillins and Streptomycins dosage market in Belgium has demonstrated significant fluctuation between 2013 and 2023. In 2023, the market size stood at 129.53 million USD. The market experienced a notable increase from 2016 to 2021, with fluctuations in percentage growth each year. The compound annual growth rate (CAGR) over the last five years was a modest 0.63%, indicating slow average growth. Over the last two years, the market saw a decline of 8.14% in 2022, followed by a slight rebound of 1.01% in 2023.

Future trends to watch for include:

  • Potential market stabilization due to steady demand in pharmaceuticals post-COVID-19.
  • Impact of regulatory changes and healthcare reforms in Belgium influencing medication pricing and distribution.
  • Technological advancements driving production efficiency and cost-effectiveness in the market.

# 33 Countries US Dollars Last Year YoY 5-years CAGR
1 1 United States 4,303,400,000 2023 +0.61% +1.48% View data
2 2 United Kingdom 730,000,000 2023 -1.31% -1.45% View data
3 3 France 717,200,000 2023 -1.91% +0.034% View data
4 4 Italy 622,330,000 2023 -3.96% -4.86% View data
5 5 Germany 476,270,000 2023 +1.03% +1.1% View data
11 11 Poland 143,340,000 2023 -0.61% -1.38% View data
12 12 South Africa 142,320,000 2023 -0.66% -0.0042% View data
13 13 Belgium 129,530,000 2023 +1.01% +0.63%
14 14 Thailand 89,928,000 2023 +4.19% +3.03% View data
15 15 Peru 80,808,000 2023 +1.93% +2.15% View data

Top Countries about Anti-Infective